Mexico Biosimilar Market Size, Share, Trends and Forecast by Molecule, Manufacturing Type, Indication and Region, 2025-2033

Mexico Biosimilar Market Size, Share, Trends and Forecast by Molecule, Manufacturing Type, Indication and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A32102

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Mexico Biosimilar Market - Introduction

4.1    Overview
4.2    Market Dynamics
4.3    Industry Trends
4.4    Competitive Intelligence
5    Mexico Biosimilar Market Landscape
5.1    Historical and Current Market Trends (2019-2024)
5.2    Market Forecast (2025-2033)
6    Mexico Biosimilar Market - Breakup by Molecule
6.1    Infliximab
6.1.1    Overview
6.1.2    Historical and Current Market Trends (2019-2024)
6.1.3    Market Forecast (2025-2033)
6.2    Insulin Glargine
6.2.1    Overview
6.2.2    Historical and Current Market Trends (2019-2024)
6.2.3    Market Forecast (2025-2033)
6.3    Epoetin Alfa
6.3.1    Overview
6.3.2    Historical and Current Market Trends (2019-2024)
6.3.3    Market Forecast (2025-2033)
6.4    Etanercept
6.4.1    Overview
6.4.2    Historical and Current Market Trends (2019-2024)
6.4.3    Market Forecast (2025-2033)
6.5    Filgrastim
6.5.1    Overview
6.5.2    Historical and Current Market Trends (2019-2024)
6.5.3    Market Forecast (2025-2033)
6.6    Somatropin
6.6.1    Overview
6.6.2    Historical and Current Market Trends (2019-2024)
6.6.3    Market Forecast (2025-2033)
6.7    Rituximab
6.7.1    Overview
6.7.2    Historical and Current Market Trends (2019-2024)
6.7.3    Market Forecast (2025-2033)
6.8    Follitropin Alfa
6.8.1    Overview
6.8.2    Historical and Current Market Trends (2019-2024)
6.8.3    Market Forecast (2025-2033)
6.9    Adalimumab
6.9.1    Overview
6.9.2    Historical and Current Market Trends (2019-2024)
6.9.3    Market Forecast (2025-2033)
6.10    Pegfilgrastim
6.10.1    Overview
6.10.2    Historical and Current Market Trends (2019-2024)
6.10.3    Market Forecast (2025-2033)
6.11    Trastuzumab
6.11.1    Overview
6.11.2    Historical and Current Market Trends (2019-2024)
6.11.3    Market Forecast (2025-2033)
6.12    Bevacizumab
6.12.1    Overview
6.12.2    Historical and Current Market Trends (2019-2024)
6.12.3    Market Forecast (2025-2033)
6.13    Others
6.13.1    Historical and Current Market Trends (2019-2024)
6.13.2    Market Forecast (2025-2033)
7    Mexico Biosimilar Market - Breakup by Manufacturing Type
7.1    In-house Manufacturing
7.1.1    Overview
7.1.2    Historical and Current Market Trends (2019-2024)
7.1.3    Market Forecast (2025-2033)
7.2    Contract Manufacturing
7.2.1    Overview
7.2.2    Historical and Current Market Trends (2019-2024)
7.2.3    Market Forecast (2025-2033)
8    Mexico Biosimilar Market - Breakup by Indication
8.1    Auto-Immune Diseases
8.1.1    Overview
8.1.2    Historical and Current Market Trends (2019-2024)
8.1.3    Market Forecast (2025-2033)
8.2    Blood Disorder
8.2.1    Overview
8.2.2    Historical and Current Market Trends (2019-2024)
8.2.3    Market Forecast (2025-2033)
8.3    Diabetes
8.3.1    Overview
8.3.2    Historical and Current Market Trends (2019-2024)
8.3.3    Market Forecast (2025-2033)
8.4    Oncology
8.4.1    Overview
8.4.2    Historical and Current Market Trends (2019-2024)
8.4.3    Market Forecast (2025-2033)
8.5    Growth Deficiency
8.5.1    Overview
8.5.2    Historical and Current Market Trends (2019-2024)
8.5.3    Market Forecast (2025-2033)
8.6    Female Infertility
8.6.1    Overview
8.6.2    Historical and Current Market Trends (2019-2024)
8.6.3    Market Forecast (2025-2033)
8.7    Others
8.7.1    Historical and Current Market Trends (2019-2024)
8.7.2    Market Forecast (2025-2033)
9    Mexico Biosimilar Market – Breakup by Region
9.1    Northern Mexico
9.1.1    Overview
9.1.2    Historical and Current Market Trends (2019-2024)
9.1.3    Market Breakup by Molecule
9.1.4    Market Breakup by Manufacturing Type
9.1.5    Market Breakup by Indication
9.1.6    Key Players
9.1.7    Market Forecast (2025-2033)
9.2    Central Mexico
9.2.1    Overview
9.2.2    Historical and Current Market Trends (2019-2024)
9.2.3    Market Breakup by Molecule
9.2.4    Market Breakup by Manufacturing Type
9.2.5    Market Breakup by Indication
9.2.6    Key Players
9.2.7    Market Forecast (2025-2033)
9.3    Southern Mexico
9.3.1    Overview
9.3.2    Historical and Current Market Trends (2019-2024)
9.3.3    Market Breakup by Molecule
9.3.4    Market Breakup by Manufacturing Type
9.3.5    Market Breakup by Indication
9.3.6    Key Players
9.3.7    Market Forecast (2025-2033)
9.4    Others
9.4.1    Historical and Current Market Trends (2019-2024)
9.4.2    Market Forecast (2025-2033)
10    Mexico Biosimilar Market – Competitive Landscape
10.1    Overview
10.2    Market Structure
10.3    Market Player Positioning
10.4    Top Winning Strategies
10.5    Competitive Dashboard
10.6    Company Evaluation Quadrant
11    Profiles of Key Players
11.1    Company A 
11.1.1    Business Overview
11.1.2    Products Offered
11.1.3    Business Strategies
11.1.4    SWOT Analysis
11.1.5    Major News and Events
11.2    Company B
11.2.1    Business Overview
11.2.2    Products Offered
11.2.3    Business Strategies
11.2.4    SWOT Analysis
11.2.5    Major News and Events
11.3    Company C
11.3.1    Business Overview
11.3.2    Products Offered
11.3.3    Business Strategies
11.3.4    SWOT Analysis
11.3.5    Major News and Events
11.4    Company D 
11.4.1    Business Overview
11.4.2    Products Offered
11.4.3    Business Strategies
11.4.4    SWOT Analysis
11.4.5    Major News and Events
11.5    Company E
11.5.1    Business Overview
11.5.2    Products Offered
11.5.3    Business Strategies
11.5.4    SWOT Analysis
11.5.5    Major News and Events

Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.

12    Mexico Biosimilar Market - Industry Analysis
12.1    Drivers, Restraints, and Opportunities
12.1.1    Overview
12.1.2    Drivers
12.1.3    Restraints
12.1.4    Opportunities
12.2    Porters Five Forces Analysis
12.2.1    Overview
12.2.2    Bargaining Power of Buyers
12.2.3    Bargaining Power of Suppliers
12.2.4    Degree of Competition
12.2.5    Threat of New Entrants
12.2.6    Threat of Substitutes
12.3    Value Chain Analysis
13    Appendix

Mexico Biosimilar Market Size, Share, Trends and Forecast by Molecule, Manufacturing Type, Indication and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials